COVID-19 Emergency

This section gathers the most relevant and updated information on ongoing trials, on medicines used outside clinical trials, on observational studies related to COVID-19 and on correct use of medicines in the population exposed to the virus.

Site Map

Informazione continua sui farmaci

PDF Ongoing information on medicinal products [0.1 Mb] >

Useful links

Ministry of Health - Novel Coronavirus

National Institute of Health - Novel Coronavirus

Questions and answers on labelling flexibilities for COVID-19 vaccines

Indicazioni ad interim sulle misure di prevenzione e controllo delle infezioni da SARS-CoV-2 in tema di varianti e vaccinazione anti-COVID-19

AIFA communications about COVID-19 emergency

17/01/2022

Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 10-13 January 2022

14/01/2022

Modifiche Registri - VEKLURY (trattamento precoce), mABs e antivirali orali Covid-19 (lagevrio)

13/01/2022

AIFA: no effective antibiotics against COVID-19

13/01/2022

Monitoring of monoclonal antibodies for COVID-19: weekly report published

10/01/2022

EMA receives application for conditional marketing authorisation for Paxlovid for treating patients with COVID-19

05/01/2022

AIFA approves Comirnaty booster dose for 12-15 year olds

05/01/2022

Monitoring of monoclonal antibodies for COVID-19: weekly report published

30/12/2021

Attivazione web e pubblicazione schede di monitoraggio - Registro VEKLURY Trattamento precoce - COVID-19

30/12/2021

Attivazione web e pubblicazione schede di monitoraggio - Registro Antivirali orali COVID-19 - LAGEVRIO (MOLNUPIRAVIR)

30/12/2021

Monitoring of monoclonal antibodies for COVID-19: weekly report published

30/12/2021

Molnupiravir and remdesivir available for the treatment of non-hospitalized COVID-19 patients at high risk of progressing to severe disease

23/12/2021

EMA recommends Nuvaxovid for authorisation in the EU

23/12/2021

Monitoring of monoclonal antibodies for COVID-19: weekly report published

22/12/2021

AIFA approves Novavax’s Covid-19 Vaccine Nuvaxovid

17/12/2021

Monitoring of monoclonal antibodies for COVID-19: weekly report published

16/12/2021

EMA recommends approval for use of Kineret in adults with COVID-19

16/12/2021

EMA issues advice on use of Paxlovid (PF-07321332 and ritonavir) for the treatment of COVID-19

16/12/2021

COVID-19: EMA recommends authorisation of antibody medicine Xevudy

15/12/2021

EMA reviewing new data on effectiveness of Lagevrio (molnupiravir) for the treatment of COVID-19

15/12/2021

COVID-19 Vaccine Janssen: EMA recommendation on booster dose

All news

— 20 Items per Page

Showing 1 - 20 of 363 results.

Site Map